JPS6426599A - Polypeptides - Google Patents

Polypeptides

Info

Publication number
JPS6426599A
JPS6426599A JP63162370A JP16237088A JPS6426599A JP S6426599 A JPS6426599 A JP S6426599A JP 63162370 A JP63162370 A JP 63162370A JP 16237088 A JP16237088 A JP 16237088A JP S6426599 A JPS6426599 A JP S6426599A
Authority
JP
Japan
Prior art keywords
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63162370A
Other languages
English (en)
Japanese (ja)
Inventor
Aruberuto Raineru
Baueru Uirufuriito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS6426599A publication Critical patent/JPS6426599A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP63162370A 1987-06-29 1988-06-28 Polypeptides Pending JPS6426599A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (1)

Publication Number Publication Date
JPS6426599A true JPS6426599A (en) 1989-01-27

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63162370A Pending JPS6426599A (en) 1987-06-29 1988-06-28 Polypeptides

Country Status (15)

Country Link
JP (1) JPS6426599A (de)
KR (1) KR890000520A (de)
AU (1) AU1840988A (de)
BE (1) BE1002663A4 (de)
CH (1) CH679045A5 (de)
DK (1) DK353788A (de)
ES (1) ES2010283A6 (de)
FR (1) FR2617171B1 (de)
GB (1) GB2206352B (de)
IL (1) IL86876A0 (de)
IT (1) IT1221065B (de)
LU (1) LU87262A1 (de)
NL (1) NL8801640A (de)
NZ (1) NZ225188A (de)
SE (1) SE8802413L (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004531520A (ja) * 2001-04-09 2004-10-14 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド ソマトスタチンアゴニスト

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
EP1198478B1 (de) * 2000-07-31 2005-03-23 Dabur Research Foundation Somatostatin analoge und deren verwendung zur behandlung von krebs
HUP0401535A3 (en) 2001-03-08 2009-07-28 Univ Tulane Somatostatin antagonists and their use
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004531520A (ja) * 2001-04-09 2004-10-14 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド ソマトスタチンアゴニスト

Also Published As

Publication number Publication date
NZ225188A (en) 1991-04-26
SE8802413L (sv) 1988-12-30
BE1002663A4 (fr) 1991-04-30
KR890000520A (ko) 1989-03-15
DK353788D0 (da) 1988-06-27
IT8848133A0 (it) 1988-06-28
FR2617171A1 (fr) 1988-12-30
GB2206352B (en) 1990-10-31
IT1221065B (it) 1990-06-21
GB8815257D0 (en) 1988-08-03
FR2617171B1 (fr) 1994-10-14
IL86876A0 (en) 1988-11-30
CH679045A5 (de) 1991-12-13
DK353788A (da) 1988-12-30
AU1840988A (en) 1989-01-05
LU87262A1 (fr) 1989-03-08
GB2206352A (en) 1989-01-05
SE8802413D0 (sv) 1988-06-28
ES2010283A6 (es) 1989-11-01
NL8801640A (nl) 1989-01-16

Similar Documents

Publication Publication Date Title
IL86700A0 (en) Polypeptides
EP0315367A3 (en) Polypeptides
GB2206352B (en) Polypeptides
GB8714802D0 (en) Synthetic polypeptides
GB8626622D0 (en) Polypeptides
ZA884655B (en) Polypeptides
GB8725598D0 (en) Polypeptides
IE872995L (en) Polypeptide
IE862882L (en) Polypeptides
IE860720L (en) Polypeptides
GB8700818D0 (en) Synthetic polypeptides
GB8700815D0 (en) Synthetic polypeptides
GB8700816D0 (en) Synthetic polypeptides
GB8700817D0 (en) Synthetic polypeptides
GB8716787D0 (en) Synthetic polypeptides
GB8716789D0 (en) Synthetic polypeptides
GB8700814D0 (en) Synthetic polypeptides
GB8716790D0 (en) Synthetic polypeptides
GB8716785D0 (en) Synthetic polypeptides
GB8716788D0 (en) Synthetic polypeptides
GB8716786D0 (en) Synthetic polypeptides
GB8700813D0 (en) Synthetic polypeptides
IE883022L (en) Polypeptides
IE881947L (en) Polypeptides
IE883303L (en) Polypeptides